SRO.574(I)/2012 is an amending notification of SRO.567(I)/2006
SRO 574(I)/2012Amendments to earlier SROs
SRO 574(I)/2012 is a Customs SRO dated 1 June 2012, listed by FBR as "SRO.574(I)/2012 is an amending notification of SRO.567(I)/2006".
The text below was extracted automatically from the text layer of the official PDF. Line breaks and table layout may differ from the original, and where FBR scanned the paper and added a machine-read text layer, that layer can contain misread characters. Check the official PDF before relying on any wording or figure.
Page 1
GOVERNMENT OF PAKISTAN
MINISTRY OF FINANCE & REVENUE
(REVENUE DIVISION)
* * * * *
Islamabad, the 1st June, 2012.
NOTIFICATION
(CUSTOMS)
S.R.O.574(I)/2012. - In exercise of the powers conferred by section 19 of the
Customs Act, 1969 (IV of 1969), the Federal Government is pleased to direct that the
following further amendments shall be made in its Notification No. S.R.O. 567(I)/2006,
dated the 5th June, 2006, namely:-
In the aforesaid Notification,-
(a) in paragraph 2,-
(i) the brackets and letters “PACCS” shall be omitted; and
(ii) in clause (a), for the expression “Ministry of Health”, the expression
“Drug Regulatory Agency of Pakistan” shall be substituted;
(b) in paragraphs 3 and 4, for the letters “PACCS”, wherever occurring, the
expression “Customs Computerized System” shall be substituted;
(c) in Table I, in column (1),-
(i) against serial number 2A, in column (2), for the PCT heading
“1701.1100” the PCT headings “1701.1300” and “1701.1400” shall
be substituted;
(ii) against serial number 4A, for the PCT heading “2909.9020” in
column (2) the PCT heading “2309.9020” shall be substituted;
Page 2
(iii) after serial number 23 and the entries relating thereto in columns
(2), (3), (4) and (5), the following new serial number and entries
relating thereto shall be inserted, namely:-
“23A 4004.0020 Shredded tyre scrap 10% If imported by
cement
manufacturers”;
(iv) against serial number 30, in column (2), the PCT headings
“8528.3090” and “8523.6990” shall be omitted;
(v) against serial number 34, in column (5), after the word “airlines” the
expression “registered in Pakistan” shall be inserted;
(vi) against serial number 36, in column (5), for the word “Nil” the
following shall be substituted, namely:-
“This concession shall be available only to those ambulances which
have following features/specifications:
i. Rear Panel and Rear Step
ii. Stretcher of 8 ft length minimum in case of hiace type vehicles and
6 ft in case of mini-van type vehicles.
iii. Folding Seats for 2-4 persons
iv. Oxygen Supply system with Cylinder
v. Rotary Lamp and Siren
vi. Fire Extinguisher
vii. Hooks for Intravenous Infusion Giving Sets / Bottles
viii. Small Cabinet for Medicines.
ix. Nebulizer, Room Light, Examination Light, Wiring Switch Sockets
12Volt
x. Water Resistant Floor
xi. Suction Unit
xii. Suspension system of base vehicle to be spring and shock
absorber type and not exclusively of leaf spring type.
xiii. Permanent markings as ambulance on the front and rear of the
vehicle
(vii) against serial number 39, for the PCT heading “87.01” in column (2)
the PCT heading “ 87.11” shall be substituted; and
Page 3
(viii) after serial number 44 and the entries relating thereto in columns
(2), (3), (4) and (5) the following new serial number and entries
relating thereto shall be inserted, namely:-
“44A 3215.1190 Black Ink 10% If imported
3215.1990 Colour Ink 10% by Printing
3701.3020 CTP Plates 5% Industry.”;
4802.5700 Fully sensitized 10%
cheque paper weighing
40 g/m2 or more but
not more than 150
g/m2
9612.1010 Red bleed through 10%
ribbons for dot matrix
printers
3215.1990 Anti-forgery security 10%
printing ink
(d) in Table III,-
(i) In the preamble, for the expression “MINISTRY OF HEALTH” the
expression “Drug Regulatory Agency of Pakistan” shall be
substituted;
(ii) under the heading “A”, after serial number 47 in column (1) and the
entries relating thereto in columns (2), (3) and (4), the following new
serial number and entries relating thereto shall be added, namely:-
48 Respective Acid Hypophosphosous 5%
headings Acid Pipmidc Trydae 5%
Acid Citric Anhydrous 5%
Propylparaben (Aseptoform-P) 5%
Methylparaben Aseptoform-M) 5%
Carbinoxamine Maleate 5%
Euflavine Bp (Acriflavine) 5%
Vancomycin Hcl 5%
Dextro-Methorph Hbr 5%
Acyclovir Usp 5%
Sodium Benzoate 5%
Sodium Sulfate 5%
Cupric Chloride 5%
Enoxacin Sesquihfrtae 5%
Mama Copolymer 5%
Page 4
Sodium Valproate 5%
Sodium Cyclamate 5%
Magnesium Hydroxide Paste 5%
Diphenhydramine 5%
Alprazolam 5%
Bacitracin Usp Powder Microniz 5%
Chloromycetin Palmitate 5%
Chlorpheniramine Maleate 5%
Esmomeprazole Magnesium Ec 5%
Fluconazole 5%
Glipizide 5%
Neomycin Sulphate 5%
Polymyxin B Sulphate USP Micro 5%
Lorazepam 5%
Nystatin Usp Powder 5%
Ferric Pyrophosphate Nf 5%
Alprazolam 5%
Pyritinol Base Fine Powder 5%
Pyritinol Di-Hcl Mono Hydrate 5%
Bisacodyl 5%
Sodium Picosulphate 5%
Carbamazepine 5%
Co-Dergocrine Ms (Gram) A 01 5%
Clemastine Hydrogen Fumarate 5%
Calcium Lactobionate Oral 5%
Clamipramine Hcl Ep 5%
Imipramine Hydrochlor/Ds 01 5%
Oxcarbazepine Fine/Ds 05 5%
Calcium Lactobionate Special Grade 5%
Temazepam Usp 28/Ep 4th Ed 5%
Levocetirizine Dihydrochloride 5%
Bromocriptine Ms(G) Msa/Ds 01 5%
Pindolol Base/Ds Pur 5%
Clopamide Base/Ds 01 5%
Pindolol Base 5%
Nimesulide 5%
Enalapril Maleate Usp 23 5%
Cetirizin Dihydrocholoride Ep 5%
Famotidine 5%
Fluoxetine Hcl 5%
Doxycycline Hydrochloride Bp 5%
Captopril 5%
Simvastatin Ep 5%
Cefaclor Monohydrate 5%
Lactulose 5%
Albendazole - Human Grade 5%
Clobetasol Propionate 5%
Betamethasone Base 5%
Betamethasone 17-Valerate 5%
Bacitracin Zinc Bp (69 Mcg/Mg) 5%
Hydrcortisone Acetate Micronised 5%
Hydrocortisone Usp Micro 5%
Clotrimazole 5%
Page 5
Clindamycin Phosphate 5%
Cetirizine Dihydrochloride 5%
Fluconazole 5%
Minocycline Hydrochloride 5%
Neomycin Sulph Bp 700 U/Mg Mic 5%
Nystatin (Mycostatin Micropul) 5%
Triprolidine Hcl B.P (94%) 5%
Ciprofloxacin Hcl 95% 5%
Ferrous Sulphate 5%
Polymyxin B Sulph Bp 8000 U/Mg 5%
Procyclidine Hcl 5%
Mupirocin 5%
Artemether 5%
Lumefantrine 5%
Desmoder H/Hexamethylen Di-Iso 5%
Erythrocin J 5%
Furosemide (Imp) 5%
Glimepiride Granules 0.606% (W/W 5%
(1 Mg)
Ketoprofen 5%
(iii) under the heading “D”, after serial number 21 in column (1) and the
entries relating thereto in columns (2), (3) and (4), the following new
serial number and entries relating thereto shall be inserted,
namely:-
“21A 4822.9000 Paper Core for Surgical Tape 5%”.
(Pharmaceutical Grade)
2. This Notification shall take effect from the 2nd June, 2012.
__________________________________________________________________
[C.No. 2(3)Tar.I/2012.Pt-III ]
(Shahid Rahim Shaikh)
Additional Secretary
Which SROs does the title refer to?
- SRO 567(I)/20065 June 2006Exemption from customs duty on import of specified goods(Non-Survey based) (Rescinded by SRO 563(I)/2014).
Related Customs SROs on amendments to earlier sros
- SRO 579(I)/20121 June 2012SRO.579(I)/2012 is an amending notification of SRO.209(I)/2009
- SRO 578(I)/20121 June 2012SRO. 578(I)/2012 is an amending notification of SRO.594(I)/2009
- SRO 577(I)/20121 June 2012SRO .577(I)/2012 is an amending notification of SRO.482(I)/2009
- SRO 576(I)/20121 June 2012SRO.576(I)/2012 is an amending notification of SRO.693(I)/2006
- SRO 575(I)/20121 June 2012SRO.575(I)/2012 is an amending notification of SRO.575(I)/2006
- SRO 573(I)/20121 June 2012SRO.573(I)/2012 is an amending notification of SRO.565(I)/2006